HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 52 filers reported holding HILLEVAX INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $138,051 | -92.6% | 10,264 | -90.6% | 0.00% | -100.0% |
| Q2 2023 | $1,873,263 | +951.6% | 108,974 | +911.3% | 0.00% | – |
| Q1 2023 | $178,127 | +41.5% | 10,776 | +43.2% | 0.00% | – |
| Q4 2022 | $125,877 | +39.9% | 7,524 | +43.1% | 0.00% | – |
| Q3 2022 | $90,000 | +34.3% | 5,259 | -14.2% | 0.00% | – |
| Q2 2022 | $67,000 | – | 6,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9,781,472 | $161,687,732 | 11.71% |
| Qiming U.S. Ventures Management, LLC | 558,923 | $9,238,997 | 11.18% |
| Samsara BioCapital, LLC | 609,862 | $10,081,019 | 2.08% |
| StepStone Group LP | 676,569 | $11,183,686 | 2.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,833,690 | $46,840,896 | 1.04% |
| Carlyle Group Inc. | 1,838,486 | $30,096,016 | 0.90% |
| BRAIDWELL LP | 1,620,216 | $26,782,170 | 0.88% |
| RA Capital Management | 1,760,019 | $29,093,114 | 0.66% |
| Perceptive Advisors | 406,024 | $6,711,577 | 0.20% |
| BVF INC/IL | 248,579 | $4,109,011 | 0.15% |